ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
|
|
Ysardine
|
24 |
9.6K |
12 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
9.6K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
IMM CHART / SP
|
|
Ysardine
|
213 |
90K |
4 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
213
|
90K
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ysardine
|
35K |
17M |
1 |
28/10/21 |
28/10/21 |
Charts
|
35K
|
17M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to present final AIPAC Overall Survival data at SITC
|
|
Ysardine
|
18 |
9.3K |
34 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
18
|
9.3K
|
34
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ysardine
|
35K |
17M |
9 |
17/09/21 |
17/09/21 |
Charts
|
35K
|
17M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Webinar
|
|
Ysardine
|
121 |
57K |
12 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
121
|
57K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Negotiate from strength ....
|
|
Ysardine
|
6 |
3.6K |
32 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
6
|
3.6K
|
32
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Ysardine
|
414 |
205K |
36 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
414
|
205K
|
36
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
Ysardine
|
23 |
7.8K |
6 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
23
|
7.8K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ysardine
|
15K |
7.6M |
11 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
15K
|
7.6M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - LR
|
|
Ysardine
|
41 |
18K |
11 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
41
|
18K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
Ysardine
|
246 |
138K |
42 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
138K
|
42
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Reveals a New anti-LAG-3 Research Program
|
|
Ysardine
|
32 |
13K |
5 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
32
|
13K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep presentation for Jefferies Healthcare Conference
|
|
Ysardine
|
140 |
55K |
3 |
05/06/21 |
05/06/21 |
ASX - By Stock
|
140
|
55K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Reports Positive Final Data from INSIGHT-004 trial
|
|
Ysardine
|
12 |
6.2K |
14 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
12
|
6.2K
|
14
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Valuation Model Indicative Price $1.33
|
|
Ysardine
|
122 |
76K |
3 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
122
|
76K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Managing Director and CEO increases shareholding in Imugene
|
|
Ysardine
|
137 |
58K |
8 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
137
|
58K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Managing Director and CEO increases shareholding in Imugene
|
|
Ysardine
|
137 |
58K |
10 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
137
|
58K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ysardine
|
27K |
13M |
29 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
27K
|
13M
|
29
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Trading Halt
|
|
Ysardine
|
21 |
7.3K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
21
|
7.3K
|
0
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Trading Halt
|
|
Ysardine
|
21 |
7.3K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
21
|
7.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
Ysardine
|
26 |
14K |
3 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
26
|
14K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Ysardine
|
127 |
65K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
127
|
65K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Ysardine
|
127 |
65K |
8 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
127
|
65K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Overall Survival data from ph IIb AIPAC breast cancer trial
|
|
Ysardine
|
248 |
116K |
21 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
248
|
116K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 2A
|
|
Ysardine
|
8 |
3.8K |
12 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
8
|
3.8K
|
12
|
|
ASX - By Stock
|
IMU |
Exercising options
|
|
Ysardine
|
8 |
3.2K |
1 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
8
|
3.2K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Letter to IMUOA & IMUOB Option Share Holders
|
|
Ysardine
|
57 |
26K |
5 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
57
|
26K
|
5
|
|
Charts
|
IMU |
Re:
Roth just rated IMU a buy
|
|
Ysardine
|
129 |
80K |
8 |
12/10/20 |
12/10/20 |
Charts
|
129
|
80K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: CEO and Managing Director increases shareholding in Imugene
|
|
Ysardine
|
145 |
70K |
11 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
145
|
70K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
Ysardine
|
1.8K |
1.0M |
25 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
1.8K
|
1.0M
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
Ysardine
|
88 |
1.5M |
9 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
88
|
1.5M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports positive TACTI-002 data
|
|
Ysardine
|
129 |
159K |
1 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
129
|
159K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports positive TACTI-002 data
|
|
Ysardine
|
129 |
159K |
6 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
129
|
159K
|
6
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Date of Quarterly Report and Briefing
|
|
Ysardine
|
16 |
9.3K |
5 |
11/10/19 |
11/10/19 |
ASX - By Stock
|
16
|
9.3K
|
5
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Change In Substantial Holding - IFM AG
|
|
Ysardine
|
14 |
6.5K |
3 |
16/07/19 |
16/07/19 |
ASX - By Stock
|
14
|
6.5K
|
3
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Change In Substantial Holding - IFM AG
|
|
Ysardine
|
14 |
6.5K |
0 |
13/07/19 |
13/07/19 |
ASX - By Stock
|
14
|
6.5K
|
0
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Malaysian Regulatory Update
|
|
Ysardine
|
35 |
14K |
5 |
31/05/19 |
31/05/19 |
ASX - By Stock
|
35
|
14K
|
5
|
|
ASX - By Stock
|
LYC |
Re:
Media Misrepresentation
|
|
Ysardine
|
31 |
13K |
8 |
27/05/19 |
27/05/19 |
ASX - By Stock
|
31
|
13K
|
8
|
|
ASX - By Stock
|
DUB |
Re:
Dubber Vs Twilio
|
|
Ysardine
|
28 |
11K |
14 |
19/05/19 |
19/05/19 |
ASX - By Stock
|
28
|
11K
|
14
|
|
ASX - By Stock
|
LYC |
Re:
Not for 48VMHs
|
|
Ysardine
|
21 |
5.1K |
1 |
29/04/19 |
29/04/19 |
ASX - By Stock
|
21
|
5.1K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Malaysian concerns over Lynas
|
|
Ysardine
|
99 |
42K |
2 |
18/04/19 |
18/04/19 |
ASX - By Stock
|
99
|
42K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Malaysian concerns over Lynas
|
|
Ysardine
|
99 |
42K |
23 |
17/04/19 |
17/04/19 |
ASX - By Stock
|
99
|
42K
|
23
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Investor Briefing
|
|
Ysardine
|
24 |
13K |
24 |
08/04/19 |
08/04/19 |
ASX - By Stock
|
24
|
13K
|
24
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC UPDATE 1-Malaysia's Mahathir says new suitors may emerge for rare-earths firm Lynas
|
|
Ysardine
|
9 |
5.5K |
7 |
06/04/19 |
06/04/19 |
ASX - By Stock
|
9
|
5.5K
|
7
|
|
ASX - By Stock
|
LYC |
Re:
What does that mean for the SP?
|
|
Ysardine
|
12 |
7.2K |
7 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
12
|
7.2K
|
7
|
|
ASX - By Stock
|
LYC |
Are WES culpable in this?
|
|
Ysardine
|
5 |
3.4K |
17 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
5
|
3.4K
|
17
|
|
ASX - By Stock
|
UWL |
Re:
Nice result
|
|
Ysardine
|
22 |
25K |
1 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
22
|
25K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Leverage... by Japan...
|
|
Ysardine
|
41 |
160K |
33 |
18/03/19 |
18/03/19 |
ASX - By Stock
|
41
|
160K
|
33
|
|
ASX - By Stock
|
LYC |
Re:
Fuziah changing her tune??
|
|
Ysardine
|
39 |
17K |
4 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
39
|
17K
|
4
|
|